Monday, February 1, 2016
Youssef Helwa, CEO of the startup NERv, used expertise gained through University of Waterloo’s Nanotechnology Engineering program to develop an implantable biochip that uses multiple biosensors to detect post-operative complications, such as inflammation, internal bleeding, bacterial infection, ischemia, and internal leakages.
NERv, co-founded by Youssef and Amr Abdelgawad, is one of the first members of the Velocity Science program. Youseff has some great advice for aspiring entrepreneurs.
Read the full story on Waterloo’s Alumni blog.
Find out more about NERv’s biodegradable chip, which is one of Waterloo’s research success stories.